Inventor

HAYDEN MICHAEL R

CA21 patents

⚠️ This page may combine multiple inventors who share the name “HAYDEN MICHAEL R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HAYDEN MICHAEL R

UNIV BRITISH COLUMBIA

Method, reagent and kit for evaluating susceptibility to premature atherosclerosis

Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents

Apoptosis modulators that interact with the Huntington&#39;s disease gene

Allele-specific therapy for huntington disease haplotypes

Gene therapy method for reducing risk of atherosclerosis

Allele-specific therapy for Huntington disease haplotypes

STAGING CONCEPTS INC

Stage system

Multipurpose adjustable panel system

Stage system with connectable corner

Staging support

Stage system with connectable corner

XENON PHARMACEUTICALS INC

Methods and reagents for modulating cholesterol levels

Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents

Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents

HAYDEN MICHAEL R

Polynucleotide encoding an ATP binding cassette transporter 1 (ABC1) polypeptide

Methods and reagents for modulating cholesterol levels

LPL variant therapeutics

XENON GENETICS INC

Process for identifying modulators of ABC1 activity

Cholesterol transport gene

AVENTIS PHARMA SA

Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same

GLICKMAN RICHARD

Treatment of vascular, autoimmune and inflammatory diseases using low dosages of IMPDH inhibitors

Apoptosis modulators that interact with the Huntington's disease gene